Abstract
We investigated whether daily oral washings with recombinant human granulocyte–macrophage colony-stimulating factor (rhGM-CSF) solution improved grade III–IV oropharyngeal mucositis (OM) in patients with hematological malignancies undergoing stem cell transplantation. Forty-one consecutive patients (21 males and 20 females, median age (range) 44 (16–69) years) were prospectively randomized to perform daily mouth-washes with either a 400 μg rhGM- CSF (Molgramostin, Schering-Plough) solution (group A, n = 18) or with a saline solution (group B, n = 23). Primary end-points were the intensity of OM, night rest quality and characteristics of food intake. Secondary end-points were need for and duration of parenteral nutrition, oral and intravenous analgesic requirements, incidence of viral or fungal oral infections and development of neutropenic fever. No differences were found between the placebo and rhGM-CSF-treated groups regarding overall duration of OM, maximum grade, reduction in at least one grade of OM (nine patients (56%) in group A vs 13 patients (68%) in group B), reduction of spontaneous or swallowing-induced pain, improvement in oral food intake, use of parenteral nutrition or use of systemic analgesics. In conclusion, mouth-washings with a 400 μg of rhGM-CSF solution do not improve severe OM in hematological patients undergoing stem cell transplantation.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Wardley AM, Jayson GC, Swindell R et al. Prospective evaluation of oral mucositis in patients receiving myeloablative conditioning regimens and haematopoietic progenitor rescue Br J Haematol 2000 110: 292 299
Pico JL, Avila-Garavito A, Nacacce P . Mucositis: Its occurrence, consequences, and treatment in the oncology setting The Oncologist 1998 3: 446 451
Wilkes JD . Prevention and treatment of oral mucositis following cancer chemotherapy Semin Oncol 1998 25: 538 551
Karthaus M, Rosenthal C, Ganser A . Prophylaxis and treatment of chemo- and radiotherapy-induced oral mucositis – are there new strategies? Bone Marrow Transplant 1999 24: 1095 1108
Lieschke GJ, Ramenghi U, O'Connor MP et al. Studies of oral neutrophil levels in patients receiving G-CSF after autologous marrow transplantation Br J Haematol 1992 82: 589 595
Katano M, Nakamura M, Matsuo T et al. Effect of granulocyte colony-stimulating factor on chemotherapy-induced oral mucositis Surg Today 1995 25: 202 206
Kannan V, Bapsy PP, Ananta N et al. Efficacy and safety of granulocyte macrophage-colony stimulating factor (GM-CSF) on the frequency and severity of radiation mucositis in patients with head and neck carcinoma Int J Radiat Oncol Biol Phys 1997 37: 1005 1010
Krawford J, Hozer H, Stoller R et al. Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small cell lungcancer New Engl J Med 1991 325: 164 170
Nemunaitis J, Rosenfeld CS, Ash R et al. A phase III randomised, double-blind placebo-control trial of rhGM-CSF following allogeneic bone marrow transplantation Bone Marrow Transplant 1995 15: 949 954
Legros M, Fleury J, Bay JO et al. RhGM-CSF vs placebo following rhGM-CSF mobilised PBPC transplantation: a phase III double-blind randomised trial Bone Marrow Transplant 1997 19: 209 213
Karthaus M, Rosenthal C, Huebner G et al. Effect of topical oral G-CSF on oral mucositis: a randomised placebo-controlled trial Bone Marrow Transplant 1998 22: 781 785
van der Lelie H, Thomas BLM, van Oers RHJ et al. Effect of locally applied GM-CSF on oral mucositis after stem cell transplantation: a prospective placebo-controlled double-blind study Ann Hematol 2001 80: 150 154
Miller AB, Hoogdtraten B, Staquet M, Winkler A . Reporting results in cancer patients Cancer 1981 47: 207 214
Rosso M, Blasi G, Gherlone E et al. Effect of granulocyte–macrophage colony-stimulating factor on prevention of mucositis in head and neck cancer patients treated with chemo-radiotherapy J Chemotherapy 1997 9: 382 385
Nicolatou O, Sotiropoulou-Lontou A, Skarlatos J et al. A pilot study of the effect of granulocyte–macrophage colony-stimulating factor on oral mucositis in head and neck cancer patients during X-radiation therapy: a preliminary report J Radiat Oncol Biol Phys 1998 42: 551 556
Cartee L, Petros WP, Rosner GL et al. Evaluation of GM-CSF mouthwash for prevention of chemotherapy induced mucositis: a randomized double-blind dose-ranging study Cytokine 1995 7: 471 477
Acknowledgements
We thank Schering-Plough for kindly supplying the rhGM-CSF. We are indebted to the nursing staff of the Clinical Hematology Unit of the Hospital de la Santa Creu i Sant Pau for their clinical assistance.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Valcárcel, D., Sanz, M., Sureda, A. et al. Mouth-washings with recombinant human granulocyte–macrophage colony stimulating factor (rhGM-CSF) do not improve grade III–IV oropharyngeal mucositis (OM) in patients with hematological malignancies undergoing stem cell transplantation. Results of a randomized double-blind placebo-controlled study. Bone Marrow Transplant 29, 783–787 (2002). https://doi.org/10.1038/sj.bmt.1703543
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1703543
Keywords
This article is cited by
-
Systematic review of growth factors and cytokines for the management of oral mucositis in cancer patients and clinical practice guidelines
Supportive Care in Cancer (2020)
-
Systematic review of cytokines and growth factors for the management of oral mucositis in cancer patients
Supportive Care in Cancer (2013)
-
Growth factors and cytokines in the prevention and treatment of oral and gastrointestinal mucositis
Supportive Care in Cancer (2006)